Cornerstone Advisors (Washington)’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | $22K | Sell |
2,435
-222
| -8% | -$2.01K | ﹤0.01% | 363 |
|
|
2020
Q2 | $33K | Buy |
2,657
+179
| +7% | +$2.22K | ﹤0.01% | 332 |
|
|
2020
Q1 | $22K | Sell |
2,478
-84
| -3% | -$746 | ﹤0.01% | 334 |
|
|
2019
Q4 | $25K | Buy |
2,562
+34
| +1% | +$332 | ﹤0.01% | 326 |
|
|
2019
Q3 | $17K | Buy |
2,528
+2,045
| +423% | +$13.8K | ﹤0.01% | 352 |
|
|
2019
Q2 | $4K | Buy |
483
+87
| +22% | +$720 | ﹤0.01% | 990 |
|
|
2019
Q1 | $6K | Buy |
396
+171
| +76% | +$2.59K | ﹤0.01% | 808 |
|
|
2018
Q4 | $3K | Sell |
225
-167
| -43% | -$2.23K | ﹤0.01% | 847 |
|
|
2018
Q3 | $8K | Buy |
392
+103
| +36% | +$2.1K | 0.01% | 696 |
|
|
2018
Q2 | $7K | Buy |
289
+48
| +20% | +$1.16K | ﹤0.01% | 679 |
|
|
2018
Q1 | $4K | Buy |
241
+154
| +177% | +$2.56K | ﹤0.01% | 747 |
|
|
2017
Q4 | $2K | Buy |
+87
| New | +$2K | ﹤0.01% | 825 |
|
|
2017
Q2 | – | Sell |
-164
| Closed | -$5K | – | 924 |
|
|
2017
Q1 | $5K | Hold |
164
| – | – | ﹤0.01% | 699 |
|
|
2016
Q4 | $6K | Sell |
164
-79
| -33% | -$2.89K | 0.01% | 683 |
|
|
2016
Q3 | $11K | Buy |
243
+31
| +15% | +$1.4K | 0.01% | 581 |
|
|
2016
Q2 | $11K | Sell |
212
-15
| -7% | -$778 | 0.01% | 412 |
|
|
2016
Q1 | $12K | Hold |
227
| – | – | 0.01% | 386 |
|
|
2015
Q4 | $15K | Hold |
227
| – | – | 0.02% | 373 |
|
|
2015
Q3 | $13K | Hold |
227
| – | – | 0.01% | 397 |
|
|
2015
Q2 | $13K | Hold |
227
| – | – | 0.01% | 303 |
|
|
2015
Q1 | $14K | Hold |
227
| – | – | 0.01% | 325 |
|
|
2014
Q4 | $13K | Buy |
227
+44
| +24% | +$2.52K | 0.01% | 294 |
|
|
2014
Q3 | $10K | Hold |
183
| – | – | 0.01% | 191 |
|
|
2014
Q2 | $10K | Hold |
183
| – | – | 0.01% | 210 |
|
|
2014
Q1 | $10K | Sell |
183
-136
| -43% | -$7.43K | 0.01% | 205 |
|
|
2013
Q4 | $13K | Hold |
319
| – | – | 0.02% | 129 |
|
|
2013
Q3 | $12K | Hold |
319
| – | – | 0.02% | 130 |
|
|
2013
Q2 | $13K | Buy |
+319
| New | +$13K | 0.03% | 76 |
|